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LABORATORY AND FIELD INVESTIGATIONS WITH DIFENACOUM, A PROMISING NEW RODENTICIDE
JOHN O. BULL, Rodenticides Section, Plant Protection Division, Imperial Chemical Industries, Fernhurst,
Haslemere, Surrey, England

ABSTRACT: Difenacoum is a new rodenticide recently introduced on the British market; it is one of
the most potent of a series of hydroxycoumarin-based anticoagulants. Difenacoum is effective
against laboratory rats and mice resistant to conventional anticoagulants and has a marked
selectivity in favour of non-target species. Vitamin K 1 is an effective antidote and the hazard of
secondary poisoning is minimal. Laboratory and field trials confirm difenacoum's efficacy against
wild resistant strains. Further work is in progress to evaluate the efficacy of difenacoum against
other rodent pest species.
INTRODUCTION
The rapid introduction of warfarin into the United Kingdom during the early 1950's provided a
much needed boost to the control of rats and mice and there was a short period during which rodent
control was easier but at the same time, more effective. This Utopian situation did not last long.
Rats resistant to both warfarin and diphacinone were soon confirmed in the Scottish Lowlands (Boyle,
1960); anticoagulant resistance was also noted in mice (Dodsworth, 1961). Since then, the incidence
of resistance has increased considerably, not only in the UK but in other countries, notably the
United States (Brooks and Bowerman, 1975; Jackson et al., 1975).
In contrast with the comparative abundance of alternative pesticides in agriculture, there was no
immediate replacement for warfarin and other anticoagulants. Since 1960, much effort has been expended
in the UK by Government (Rowe et al., 1970) and private companies (Bull, 1967) to find alternative
compounds.
Routine screening of toxic materials rejected by the pharmaceutical industry for human use proved
time consuming and few compounds reached even the field trials stage (Rowe, 1970). Routine synthesis of
new compounds in the pharmaceutical industry has thrown up very few promising new rodenticides, notably
norbormide, parachlorphenyl silatrane (Beiter et al., 1970) and a series of compounds from Rohm & Haas
(Peardon, 1974). The two former compounds have not fulfilled their initial promise (Rennison et al.,
1968) and are now little used, while only one of the Rohm & Haas series (787) has reached registration
and marketing in the United States.
A more fundamental approach was adopted by Hadler and Shadbolt (1975) who, after carefully
examining the current evidence on anticoagulant resistance and coagulation theory, proceeded to
synthesize a series of hydroxycoumarin-based anticoagulants, many of which showed exceptional potency to
both normal and anticoagulant resistant rats. One of the most potent of the series is 3-(3-P-dipheny11,2,3,4-tetrahydronaphth-1-yl)-4-hydroxycoumarin, the proposed British Standard Common name being
difenacoum. The present paper examines the properties and toxicity of difenacoum and reviews laboratory
and field performance in the UK and other parts of the world.
STRUCTURE OF DIFENACOUM
The anticoagulant coumatetraly1 has a higher activity than warfarin against resistant strains of
Rattus norvegicus (Lund, 1972) possibly related to the size and complexity of the groups attached to the
4-hydroxycoumarin. The rationale of Hadler and Shadbolt (loc. cit) in synthesizing compounds with
substituted phenyl groups attached by a three carbon chain to the 4-hydroxycoumarin moiety is
illustrated in Figure 1. Fuller details of the chemistry and structure/activity relationships are given
in the original paper.
TOXICITY
a) Acute
Difenacoum is highly active against a number of important rodent species (Table 1). In
contrast with warfarin, difenacoum is more toxic to the Mus musculus than to Rattus norvegicus.
A l th o ug h t he da t a ar e l i mi t ed , t he su s ce pt i bi l it i es o f R a tt u s r a t tu s a n d it s
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Figure 1. Comparative structures of three
rodenticides.
sub-species are of the same order as that of R. norvegicus. This again contrasts with
warfarin since R. rattus has required a concentration about five times more than that for R.
norvegicus (Bentley and Larthe, 1959).
For non-target species, difenacoum is much less toxic; in particular the pig is far
less susceptible than to warfarin (Papworth, 1958) for which a dose of 1 mg/kg has been
recorded as lethal.
b)

Chronic

Groups of male Wistar rats and male LAC mice were given a graded series of doses of
difenacoum on five consecutive days to establish its cumulative toxicity vis-a-vis warfarin. The
chronic oral LD 50 was established as 5 x 0.15 mg/kg for rats and 5 x 0.07 mg/kg for mice. In
each instance the cumulative dose was about half of the acute. A similar test on homozygous
resistant (Welsh strain) R. norvegicus gave 5 x 0.54 mg/kg, from which a resistance factor of
about x 3 can be deduced in comparison with non-resistant animals.
At first sight, the activity of difenacoum seems to differ from warfarin for which the
ratio of acute to chronic dose is taken to be large, i.e. > 50 mg/kg: 5 x 0.5 mg/kg (Hayes and
Gaines, 1950). Reviewing other work on warfarin, Bentley and Larthe (1959) list acute oral LD 50
values ranging from 1.3-323 mg/kg the most widely quoted being 60 mg/kg. Because of these
disparities and to allow valid comparison of warfarin with difenacoum, new
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determinations have been made. The oral LD 50 of high purity warfarin in glycol solution to
female rats was 8.5 mg/kg, 95% confidence limits 4-15 mg/kg (M.Hadler, personal communication).
The LD 50 of an aqueous suspension of warfarin was 6.9 mg/kg, 95% confidence limits 4.3-ll (R.
Parkinson, personal communication).
These data on warfarin indicate that the ratio of chronic to acute is less than has been
widely accepted and that the safety margin may be less than has been supposed. Further work is
in progress to resolve the apparent discrepancy.
c)

Hazards to domestic animals

High potency per se is sometimes taken out of context and without reference to the end-use
concentration. Data is therefore included on various rodenticide to compare their hazards to nontarget species (Table 2). The calculations for warfarin are based on early published work and
take no account of the data given in the previous paragraph. The margins of safety offered by
difenacoum need no further comment.
Table 2. Amount of bait (grams) required to deliver 1 acute LD 50 dose of various rodenticides
to different species.

TOXICITY OF IMPURITIES PRESENT IN DIFENACOUM
Analysis shows two main impurities in difenacoum; 4-hydroxycoumarin and 2-p-diphenyl -1,2dihydronaphthalene. Oral dosing of these compounds in polyethylene glycol to mice gave acute oral
LD 50’s of >200 mg/kg and 180 mg/kg respectively. The corresponding LD 50 for difenacoum against
mice is 0.8 mg/kg and since neither of the impurities is present at more than 2-3% in technical
difenacoum they can be ignored as toxic components .
ANTICOAGULANT ACTIVITY
The structure, method of synthesis and mode of action of difenacoum are a l l characteri s t i c of a classical i n d i r e c t anticoagulant. The a c t i v i t y of difenacoum was compared w i t h
that of some other commonly used anticoagulants against W i s t a r Rats (Fig. 2); the most active
of the warfarin isomers (s-) was the least effective compound tested and difenacoum the most
effective w i t h the other three compounds b e i n g intermediate. For homozygous resistant (Welsh
strain) rats, differences between compounds were enormous (Fig. 3). The resistance factors
between the s t r a i n s varied from x 2 for difenacoum to about x 227 for diphacinone
(Hadler, 1975a).
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Figure 3. The effect on the extension of prothrombin times of
homozygous resistant (Welsh strain) male rats following three
d a i l y oral administrations of various rodenticides.
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ANTIDOTE STUDIES
Vitamins K 3 and K 1 were tested as possible antidotes to difenacoem. As expected,
V i t am in K3 was almost inactive; Vitamin K1 was much more effective. A single dose of 2
mg/kg difenacoum k i l l e d 8/10 male mice (Fig. 4) w h i l e o n l y 2/10 d i e d when protected by
d a i l y injections of 10 mg/kg V i t a m i n K 1 . More d e t a i l e d examination of the optimum dose for
rats (Hadler, in preparation) has shown that doses of 10 mg/kg V i t a m i n K 1 w i l l provide
effective protection against difenacoum at a l l l e v e l s up to 50 mg/kg. T h i s compares w i t h
work on warfarin for which 1 mg/kg V i t a m i n K 1 w i l l protect against any level (Lowenthal and
Macfarlane, 1964; Lowenthal and Birnbaum, 1969). The higher level of V i t a m i n K 1 required
for difenacoum may o n l y reflect the higher potency of the rodenticide but the data also
i n d i c a t e the prolonged action of difenacoum and underline the need for careful monitoring of
antidotal measures taken in instances of accidental poisoning. However the delay of up to
three days before death occurs is more than adequate time for i n s t i g a t i o n of effective
prophylactic measures.

Figure 4. The effect of V i t a m i n K1 in reversing the anticoagulant
action of a s i n g l e dose of difenacoum given to LAC mice.
SECONDARY TOXICITY
Anticoagulants in general have a good record regarding toxicity to predators feeding
on poisoned rodents. The possible hazard of difenacoum was elevated by feeding poisoned
mice to rats for e i t h e r one or three days.
Determination of rat prothrombin times 24 hours after completion of feeding showed
s l i g h t l y greater elevation w i t h warfarin than with difenacoum for the one day feed (Table 3);
the s i t u a t i o n was reversed for the three day feed, probably the result of the more prolonged
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action of difenacoum. However the results are s u f f i c i e n t l y close to suggest that difenacoum
is u n l i k e l y to offer significantly greater hazard than warfarin to non-target species.
Table 3. The effect on prothrombin times of rats fed w i t h difenacoum poisoned mice.

LONG TERM FEEDING STUDIES
Although all available evidence showed that difenacoum acted only as an indirect
anticoagulant, laboratory rats and mice were fed continuously with low concentrations of
difenacoum (0.1 ppm and 0.5 ppm respectively) in their diet for 12 weeks to elucidate other
possible effects. During this period 3.13 mg/kg was consumed by rats and 1.48 mg/kg by
mice (about 2 LD 50 ' S in each case). Four out of 12 male rats died in weeks 10 and 11 and
one female in week eleven; only 2/25 male mice died. All deaths were attributable to
classical anticoagulant hemorrhaging; moreover, histological examination detected no
abnormalities in the organs of animals of either species.
BAIT FEEDING STUDIES
Baits were fed to homozygous resistant R. norvegicus to compare the activity of
difenacoum with other rodenticides. Coumatetralyl again showed its superiority over other
conventional anticoagulants but was much less effective than difenacoum which gave significant mortality even at 10 ppm (Table 4).
Table 4. Ten day no choice bait trials in female homozygous resistant (Welsh strain
R. norvegicus 1 .

More detailed studies at the Toworth Laboratories of the Ministry of Agriculture,
Fisheries and Food on 0.005% difenacoum bait were made with R. norvegicus, R. rattus and Mus
musculus (Hadler, Redfern and Rowe, 1975). These tests confirmed the efficacy of difenacoum
in two day no-choice feeding (Table 5). Non-resistant rats were all killed; 9/10 and 5/10
respectively of the resistant strains succumbed. Mice were less susceptible with 9/10 nonresistant and 13/15 resistant mice being killed. In similar tests with warfarin, a kill of
21/23 was obtained with non-resistant rats (Bentley and Larthe, loc. cit.) whereas no
resistant rats would die.
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Choice tests were carried out on the three species using different feeding periods with
various concentrations (Table 6). High concentrations of difenacoum were clearly unacceptable to
M. musculus and R. norvegicus; at 0.005% there was still some discrimination by the latter
against difenacoum but kills were excellent. A further test comparing the acceptance of 0.025%
warfarin with 0.005% difenacoum showed insignificant preference for difenacoum.
Further tests on house mice in large pens confirmed that longer feeding periods were
required to get good control and that slightly higher concentrations might be required (Table
7). However the Cambridge strain of mice used in this experiment is known to have exceptional
resistance to anticoagulants; field strains are likely to be more susceptible and more readily
controlled by difenacoum than the results above would suggest.
Table 7.

Summary of tests on house mice in pens (after Rowe, 1975).

% Difenacoum

No. mice
tested

0.005%

81

0.010%

67

No. killed

% kill

Days to death

72

89

3-23

65

97

3-15

FIELD TRIALS
Difenacoum was tested on a number of farms in Wales and in Kent, since the resistant rats
in these two areas probably represented different genetic strains (Rennison and Hadler, 1975).
Three farms were treated first with 0.025% warfarin and, not unexpectedly, all treatments were
unsuccessful; the farms were then treated with 0.005% difenacoum and the rat infestations were
eradicated (Fig. 5). Eleven further farms were treated with 0.005% difenacoum and six farms with
0.010% difenacoum. The results showed that difenacoum effectively controlled warfarin resistant
rats in both areas; no practical difference could be demonstrated between the two concentrations
used and the lower concentration was therefore, chosen for field use. Since Autumn 1974,
difenacoum (under the trade name of "NeoSorexa", registered trade mark of Ward Blenkinsop & Co.
Ltd.) bait has been commercially available to professional pest control operators, local
authorities and large agricultural users and has proved remarkably successful.
TESTS ON OTHER STRAINS AND SPECIES
Difenacoum at 0.01% has also been tested against American strains of anticoagulant
resistant R. norvegicus (Table 8) as well as R. r. mindanensis from the Philippines and R.
exulans from Hawaii (Scott, DWRC, personal communication). The results were promising and further
work is planned to test difenacoum under field conditions. Preliminary tests by Brooks and
Bowerman (personal communication) conducted on five resistant Norway rats from Chicago gave 100%
mortality with 0.005% difenacoum after a 6 day no-choice feeding test. One hundred percent
mortality of eight resistant house mice (Mus musculus) was also obtained after a 21 day no-choice
test with 0.005% difenacoum. Jackson (personal communication) has also conducted preliminary
laboratory trials with 0.005% difenacoum baits on 10 Chicago resistant rats with complete
mortality after a 6 day, no-choice test. In view of these results and preliminary genetic data
obtained for American resistant rats by Brooks and Bowerman (loc. cit), it is expected that
difenacoum will perform well under American conditions.
Danish resistant rats (Lund, 1975) all died when subjected to the standard 6 day
feeding regime (Table 9).
Evaluations of difenacoum against Rattus tiomanicus, an important pest of oil palm, and
Rattus argentiventer a rice field rat have shown promising results (B.J. Wood, personal
communication). Difenacoum at 0.01% killed all R. tiomanicus whether they ate 20g bait/day or
were restricted to 5g (Fig. 6). Even 0.001% under the latter regime killed nearly 90% of rats.
Comparative field trials in oil palm have confirmed the promise of laboratory tests (Table 10:
B.J. Wood, personal communication). Difenacoum at 0.0055% gave equivalent results to warfarin
at 0.05% but 0.0275% difenacoum was more effective in that half the previous number of rounds
and baits were needed to obtain control. Further work is planned to determine the optimum
concentration for use against R. argentiventer.
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Figure 5. The regression of rat populations on three farms after
treatment with 0.025% warfarin (broken lines) and afterwards with
0.005% difenacoum (solid lines). Taken from Rennison and Hadler, 1975.
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Table 10. Results of field trials with difenacoum-based wax cubes against Rattus tiomanicus
under oil palms.

Arvicanthis niloticus (Nile, grass or harsh furred rat) is a serious agricultural pest
in Africa and parts of the Arabian peninsula. From comparative laboratory tests (Gill and
Redfern, Pans in press) it appears that there is a factor of about x 7 in toxicity of 0.005%
difenacoum over 0.025% warfarin; 100% kill was achieved after 2-3 days no choice feeding
compared with 5-6 days with warfarin. Overall, the susceptibility of Arvicanthis to difenacoum
appears to fall between that of R. norvegicus and R. rattus (Anon., 1970). Gill and Redfern
conclude that all the rodenticides tested, in suitable bait formulations, would be effective as
practical control agents but rightly stress the need for practical field evaluation before
definite conclusions can be drawn.
CONCLUSIONS
Difenacoum is still in an early stage of development and much work remains to be done but
the product appears to be one of the most exciting developments in rodent control for many
years. It has all the benefits of the 'classical' anticoagulants and a wide spectrum of action
against rodents, with the additional advantages of being active against anticoagulant
resistant rats and having a marked degree of selectivity towards non-target species.
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